Poland· PL-100095457
Cerebrolysin
A medicinal product containing celebrolysinum, registered in Poland by Ever Neuro Pharma GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Celebrolysinum
- Manufacturer
- Ever Neuro Pharma GmbH
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990813513
- gtin05909990813520
- gtin05909990813537
- gtin05909991410599
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9118c7fd-82c5-4954-b829-0d3559b5cdd1 GET /v1/drugs/9118c7fd-82c5-4954-b829-0d3559b5cdd1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań i infuzji",
"source": "urpl",
"strength": "215,2 mg/ml",
"packaging": "05909990813513 ¦ Rp ¦ 15890\n10 amp. 1 ml\n05909990813520 ¦ Rp ¦ 15891\n5 amp. 5 ml\n05909990813537 ¦ Rp ¦ 15892\n5 amp. 10 ml\n05909991410599 ¦ Rp ¦ 133531\n10 amp. 2 ml",
"substance": "Cerebrolysinum 215.2 mg/ml",
"common_name": "Celebrolysinum",
"pl_product_id": "100095457",
"pozwolenie_nr": "08135",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about celebrolysinum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.